{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:48:41Z","timestamp":1790196521411,"version":"4.1.0"},"reference-count":90,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>In recent years, there has been a growing interest in the gut microbiome and its potential role in the etiopathogenesis of both gastrointestinal and extraintestinal diseases. Dysbiosis, characterized by a pathological alteration in the composition of the gut microbiome, has been implicated in various gastrointestinal diseases. This paradigm extends to pregnancy-specific conditions, including intrahepatic cholestasis of pregnancy (ICP). ICP exhibits a multifactorial etiopathogenesis, involving hormonal, genetic and environmental factors, among others. Despite growing scientific evidence, there is currently a lack of comprehensive reviews that specifically examine the causal mechanisms through which gut microbiota dysbiosis might contribute to the pathogenesis of ICP, as well as the resulting implications for the development of new targeted therapeutic approaches. Notably, shifts in microbial taxa and the depletion of bacteria involved in certain metabolic pathways have been observed in ICP. These findings suggest that alterations in the gut microbiome composition may contribute to the pathophysiology of ICP. Such microbiome-associated alterations may have important implications for risk stratification and early identification of patients at increased risk of adverse maternal and fetal outcomes. Further investigation into these microbial changes and molecular pathways could offer novel insights and identify potential pharmacological targets for ICP development and management. In particular, modulation of the gut microbiome could represent a future adjunctive strategy to existing therapeutic approaches, potentially improving disease monitoring and individualized management. The precise role of gut microbiome composition in the management and treatment of ICP is still not fully understood, highlighting the need for a systematic review to synthesize existing evidence and identify critical gaps relevant to the future development of screening, prevention, and targeted therapeutic strategies.<\/jats:p>","DOI":"10.3389\/fmed.2026.1859397","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T05:56:26Z","timestamp":1781675786000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["The impact of gut microbiome on intrahepatic cholestasis of pregnancy\u2014systematic literature review"],"prefix":"10.3389","volume":"13","author":[{"given":"Florence Julie","family":"Donz\u00e9","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of Bern","place":["Bern, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Eli","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Bern","place":["Bern, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Di Simone","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University","place":["Milan, Italy"]},{"name":"IRCCS Humanitas Research Hospital","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara Baur","family":"Cavegn","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Lindenhofgruppe AG","place":["Bern, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Mueller","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Lindenhofgruppe AG","place":["Bern, Switzerland"]},{"name":"Institute of Biochemistry and Molecular Medicine, University of Bern","place":["Bern, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1080\/17474124.2021.2011211","article-title":"Research progress in the role of gut microbiota and its metabolites in intrahepatic cholestasis of pregnancy","volume":"15","author":"Ren","year":"2021","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/s41467-023-36981-4","article-title":"Gut microbiota alters host bile acid metabolism to contribute to intrahepatic cholestasis of pregnancy","volume":"14","author":"Tang","year":"2023","journal-title":"Nat Commun"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.12998\/wjcc.v10.i10.2976","article-title":"Gut microbiota in gastrointestinal diseases during pregnancy","volume":"10","author":"Liu","year":"2022","journal-title":"World J Clin Cases"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00129-021-04787-4","article-title":"Intrahepatic cholestasis of pregnancy","volume":"54","author":"Hagenbeck","year":"2021","journal-title":"Gynakologe"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1124\/jpet.104.079665","article-title":"Protective effects of 6-ethyl Chenodeoxycholic acid, a Farnesoid X receptor ligand, in estrogen-induced cholestasis","volume":"313","author":"Fiorucci","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"ref6","first-page":"18","volume-title":"Digestive Disease Week 2019","year":""},{"key":"ref7","doi-asserted-by":"publisher","first-page":"G197","DOI":"10.1152\/ajpgi.00126.2020","article-title":"Obeticholic acid improves fetal bile acid profile in a mouse model of gestational hypercholanemia","volume":"319","author":"Pataia","year":"2020","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.tibtech.2015.06.011","article-title":"Proteobacteria: microbial signature of dysbiosis in gut microbiota","volume":"33","author":"Shin","year":"2015","journal-title":"Trends Biotechnol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1038\/s41598-020-60821-w","article-title":"Ursodeoxycholic acid enriches intestinal bile salt hydrolase-expressing Bacteroidetes in cholestatic pregnancy","volume":"10","author":"Ovadia","year":"2020","journal-title":"Sci Rep"},{"key":"ref10","first-page":"1","article-title":"Eubiosis and dysbiosis: the two sides of the microbiota","volume":"39","author":"Valerio Iebba","year":"2016","journal-title":"New Microbiol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/nrmicro.2017.58","article-title":"The resilience of the intestinal microbiota influences health and disease","volume":"15","author":"Sommer","year":"2017","journal-title":"Nat Rev Microbiol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00248-010-9801-8","article-title":"Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients","volume":"61","author":"Lu","year":"2011","journal-title":"Microb Ecol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/nature16504","article-title":"Diet-induced extinctions in the gut microbiota compound over generations","volume":"529","author":"Sonnenburg","year":"2016","journal-title":"Nature"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s12072-023-10604-y","article-title":"Intrahepatic cholestasis of pregnancy: insights into pathogenesis and advances in omics studies","volume":"18","author":"Tang","year":"2024","journal-title":"Hepatol Int"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.1016\/j.apsb.2021.05.023","article-title":"Bile acid homeostasis in female mice deficient in Cyp7a1 and Cyp27a1","volume":"11","author":"Rizzolo","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/MOG.0000000000000057","article-title":"Bile acids and the gut microbiome","volume":"30","author":"Ridlon","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"R69","DOI":"10.1530\/EJE-20-1101","article-title":"ENDOCRINOLOGY IN PREGNANCY: metabolic impact of bile acids in gestation","volume":"184","author":"Fan","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"108392","DOI":"10.1016\/j.isci.2023.108392","article-title":"Roseburia intestinalis relieves intrahepatic cholestasis of pregnancy through bile acid\/FXR-FGF15 in rats","volume":"26","author":"Sun","year":"2023","journal-title":"iScience"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e00329","DOI":"10.1002\/prp2.329","article-title":"Obeticholic acid, a selective farnesoid X receptor agonist, regulates bile acid homeostasis in sandwich-cultured human hepatocytes","volume":"5","author":"Zhang","year":"2017","journal-title":"Pharmacol Res Perspect"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a nuclear receptor for bile acids","volume":"284","author":"Makishima","year":"1999","journal-title":"Science"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1053\/gast.2001.25503","article-title":"The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp","volume":"121","author":"Denson","year":"2001","journal-title":"Gastroenterology"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"28857","DOI":"10.1074\/jbc.M011610200","article-title":"Human bile salt export pump promoter is transactivated by the farnesoid X receptor\/bile acid receptor","volume":"276","author":"Ananthanarayanan","year":"2001","journal-title":"J Biol Chem"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.bbrc.2019.09.103","article-title":"Probiotic Lactobacillus rhamnosus GG prevents progesterone metabolite epiallaopregnanolone sulfate-induced hepatic bile acid accumulation and liver injury","volume":"520","author":"Ren","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/s12876-020-01510-w","article-title":"Characterization of gut microbiota associated with clinical parameters in intrahepatic cholestasis of pregnancy","volume":"20","author":"Li","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"635680","DOI":"10.3389\/fcimb.2021.635680","article-title":"Alterations of the human gut microbiota in intrahepatic cholestasis of pregnancy","volume":"11","author":"Zhan","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"7338","DOI":"10.3748\/wjg.v26.i46.7338","article-title":"Response of gut microbiota to serum metabolome changes in intrahepatic cholestasis of pregnant patients","volume":"26","author":"Li","year":"2020","journal-title":"World J Gastroenterol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1186\/s12884-023-05889-8","article-title":"Causal association between gut microbiota and intrahepatic cholestasis of pregnancy: mendelian randomization study","volume":"23","author":"Li","year":"2023","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1186\/s12884-022-05235-4","article-title":"Distribution of endotoxin in maternal and fetal body with intrahepatic cholestasis of pregnancy and its association with adverse fetal outcome","volume":"22","author":"Huang","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1053\/j.gastro.2024.06.014","article-title":"AGA clinical practice update on pregnancy-related gastrointestinal and liver disease: expert review","volume":"167","author":"Kothari","year":"2024","journal-title":"Gastroenterology"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/ajg.2015.430","article-title":"ACG clinical guideline: liver disease and pregnancy","volume":"111","author":"Tran","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"44","DOI":"10.14309\/ajg.0000000000001960","article-title":"Liver disease during pregnancy","volume":"117","author":"Reau","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/sj.embor.7400731","article-title":"The gut flora as a forgotten organ","volume":"7","author":"O'Hara","year":"2006","journal-title":"EMBO Rep"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nature11550","article-title":"Diversity, stability and resilience of the human gut microbiota","volume":"489","author":"Lozupone","year":"2012","journal-title":"Nature"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature08821","article-title":"A human gut microbial gene catalogue established by metagenomic sequencing","volume":"464","author":"Qin","year":"2010","journal-title":"Nature"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1177\/03946320261432321","article-title":"Gut microbiota and the immune system: an intimate partnership in health and disease","volume":"25","author":"Iebba","year":"2012","journal-title":"Int J Immunopathol Pharmacol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.coi.2010.06.008","article-title":"Microbiota-stimulated immune mechanisms to maintain gut homeostasis","volume":"22","author":"Chung","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1210\/me.2014-1108","article-title":"Minireview: gut microbiota: the neglected endocrine organ","volume":"28","author":"Gerard Clarke","year":"2014","journal-title":"Mol Endocrinol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.celrep.2019.03.075","article-title":"Progesterone increases Bifidobacterium relative abundance during late pregnancy","volume":"27","author":"Nuriel-Ohayon","year":"2019","journal-title":"Cell Rep"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.1016\/j.celrep.2017.12.027","article-title":"Shaping of intestinal microbiota in Nlrp6- and Rag2-deficient mice depends on community structure","volume":"21","author":"Galvez","year":"2017","journal-title":"Cell Rep"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1126\/science.aau5812","article-title":"The gut microbiota at the intersection of diet and human health","volume":"362","author":"Gentile","year":"2018","journal-title":"Science"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nri.2016.42","article-title":"Gut microbiota, metabolites and host immunity","volume":"16","author":"Rooks","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"127","DOI":"10.5217\/ir.2016.14.2.127","article-title":"Pathogenic role of the gut microbiota in gastrointestinal diseases","volume":"14","author":"Nagao-Kitamoto","year":"2016","journal-title":"Intest Res"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nature23910","article-title":"Maternal gut bacteria promote neurodevelopmental abnormalities in mouse offspring","volume":"549","author":"Kim","year":"2017","journal-title":"Nature"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1126\/science.aar3318","article-title":"Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection","volume":"359","author":"Christoph","year":"2018","journal-title":"Science"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1136\/gut.30.Spec_No.22","article-title":"Intestinal permeability, non-steroidal anti-inflammatory drug enteropathy and inflammatory bowel diseas: an overview","volume":"30","author":"Bjarnason","year":"1989","journal-title":"Gut Festschritft"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12866-023-02983-x","article-title":"Profiles and integration of the gut microbiome and fecal metabolites in severe intrahepatic cholestasis of pregnancy","volume":"23","author":"Li","year":"2023","journal-title":"BMC Microbiol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"261","DOI":"10.26402\/jpp.2022.2.09","article-title":"Resveratrol modulates the gut microbiota of cholestasis in pregnant rats","volume":"73","author":"Li","year":"2022","journal-title":"J Physiol Pharmacol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst Rev"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.cell.2012.07.008","article-title":"Host remodeling of the gut microbiome and metabolic changes during pregnancy","volume":"150","author":"Koren","year":"2012","journal-title":"Cell"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41522-020-00142-y","article-title":"Systematic analysis of gut microbiota in pregnant women and its correlations with individual heterogeneity","volume":"6","author":"Yang","year":"2020","journal-title":"NPJ Biofilms Microbiomes"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/j.1472-765X.2007.02129.x","article-title":"Cultivable bacterial diversity from the human colon","volume":"44","author":"Duncan","year":"2007","journal-title":"Lett Appl Microbiol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/hep.30661","article-title":"Enhanced microbial bile acid Deconjugation and impaired Ileal uptake in pregnancy repress intestinal regulation of bile acid synthesis","volume":"70","author":"Ovadia","year":"2019","journal-title":"Hepatology"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/19490976.2016.1203502","article-title":"Sex differences and hormonal effects on gut microbiota composition in mice","volume":"7","author":"Org","year":"2016","journal-title":"Gut Microbes"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s40168-020-00913-x","article-title":"Gut microbiota steroid sexual dimorphism and its impact on gonadal steroids: influences of obesity and menopausal status","volume":"8","author":"Mayneris-Perxachs","year":"2020","journal-title":"Microbiome"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"G310","DOI":"10.1152\/ajpgi.00282.2013","article-title":"Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection","volume":"306","author":"Weingarden","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1194\/jlr.M075143","article-title":"Comprehensive evaluation of the bactericidal activities of free bile acids in the large intestine of humans and rodents","volume":"58","author":"Watanabe","year":"2017","journal-title":"J Lipid Res"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1136\/gut.39.4.587","article-title":"Role of the gut in the pathophysiology of extrahepatic biliary obstruction","volume":"39","author":"Clements","year":"1996","journal-title":"Gut"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000129252","article-title":"The role of bile and bile acids in bacterial translocation in obstructive Jandice in rats","volume":"25","author":"Ding","year":"1993","journal-title":"Eur Surg Res"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1194\/jlr.R054114","article-title":"Intestinal transport and metabolism of bile acids","volume":"56","author":"Dawson","year":"2015","journal-title":"J Lipid Res"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrgastro.2013.151","article-title":"Bile acid receptors as targets for drug development","volume":"11","author":"Schaap","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mib.2017.07.003","article-title":"Dysbiotic Proteobacteria expansion: a microbial signature of epithelial dysfunction","volume":"39","author":"Litvak","year":"2017","journal-title":"Curr Opin Microbiol"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/hep.24525","article-title":"The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light-chain enhancer of activated B cells (NF-kappaB) in mice","volume":"54","author":"Wang","year":"2011","journal-title":"Hepatology"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1194\/jlr.M700330-JLR200","article-title":"Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine","volume":"49","author":"Kim","year":"2008","journal-title":"J Lipid Res"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1016\/j.jceh.2014.12.003","article-title":"Gut microbiota: its role in hepatic encephalopathy","volume":"5","author":"Rai","year":"2015","journal-title":"J Clin Exp Hepatol"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"10-1128","DOI":"10.1128\/IAI.00861-18","article-title":"The autotransporter IcsA promotes Shigella flexneri biofilm formation in the presence of bile salts","volume":"87","author":"Koseoglu","year":"2019","journal-title":"Infect Immun"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"10-1128","DOI":"10.1128\/IAI.01067-16","article-title":"Analysis of Shigella flexneri resistance, biofilm formation, and transcriptional profile in response to bile salts","volume":"85","author":"Nickerson","year":"2017","journal-title":"Infect Immun"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"11450","DOI":"10.1038\/s41598-017-11734-8","article-title":"Butyrate-producing bacteria supplemented in vitro to Crohn's disease patient microbiota increased butyrate production and enhanced intestinal epithelial barrier integrity","volume":"7","author":"Geirnaert","year":"2017","journal-title":"Sci Rep"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cca.2018.04.035","article-title":"Diagnostic and therapeutic profiles of serum bile acids in women with intrahepatic cholestasis of pregnancy-a pseudo-targeted metabolomics study","volume":"483","author":"Cui","year":"2018","journal-title":"Clin Chim Acta"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0301-2115(98)00086-4","article-title":"Relevance of serum bile acid profile in the diagnosis of intrahepatic cholestasis of pregnancy in an high incidence area: Portugal","volume":"80","author":"Brites","year":"1998","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/ajg.2009.633","article-title":"Longitudinal profiles of 15 serum bile acids in patients with intrahepatic cholestasis of pregnancy","volume":"105","author":"Tribe","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"848508","DOI":"10.3389\/fphys.2022.848508","article-title":"Circulatory metabolomics reveals the Association of the Metabolites with Clinical Features in the patients with intrahepatic cholestasis of pregnancy","volume":"13","author":"Liu","year":"2022","journal-title":"Front Physiol"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"10-1128","DOI":"10.1128\/mBio.02392-17","article-title":"Structural alteration of gut microbiota during the amelioration of human type 2 diabetes with hyperlipidemia by metformin and a traditional Chinese herbal formula: a multicenter, randomized, open label clinical trial","volume":"9","author":"Tong","year":"2018","journal-title":"MBio"},{"key":"ref73","first-page":"870","article-title":"Induction of Labour. Guideline of the DGGG, OEGGG and SGGG (S2k, AWMF Registry No. 015-088, December 2020)","volume-title":"Geburtshilfe Frauenheilkd","author":"Kehl","year":"2021"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1002\/hep.20952","article-title":"Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid","volume":"42","author":"Glantz","year":"2005","journal-title":"Hepatology"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0022-2275(20)37344-2","article-title":"In vitro transformation of chenodeoxycholic acid and ursodeoxycholic acid by human intestinal flora, with particular reference to the mutual conversion between the two bile acids","volume":"22","author":"Hirano","year":"1981","journal-title":"J Lipid Res"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.3389\/fphar.2020.01249","article-title":"Resveratrol modulates the gut microbiota and inflammation to protect against diabetic nephropathy in mice","volume":"11","author":"Cai","year":"2020","journal-title":"Front Pharmacol"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.drudis.2012.05.012","article-title":"Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis","volume":"17","author":"Adorini","year":"2012","journal-title":"Drug Discov Today"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3978\/j.issn.2305-5839.2014.12.06","article-title":"Recent advances in the development of farnesoid X receptor agonists","volume":"3","author":"Ali","year":"2015","journal-title":"Ann Transl Med"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/antiox13010008","article-title":"Chenodeoxycholic acid improves embryo implantation and metabolic health through modulating gut microbiota-host metabolites interaction during early pregnancy","volume":"13","author":"Chen","year":"2023","journal-title":"Antioxidants"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.taap.2016.10.011","article-title":"UDCA and CDCA alleviate 17alpha-ethinylestradiol-induced cholestasis through PKA-AMPK pathways in rats","volume":"311","author":"Li","year":"2016","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"889646","DOI":"10.3389\/fimmu.2022.889646","article-title":"Intrahepatic cholestasis of pregnancy increases inflammatory susceptibility in neonatal offspring by modulating gut microbiota","volume":"13","author":"Lin","year":"2022","journal-title":"Front Immunol"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"a040501","DOI":"10.1101\/cshperspect.a040501","article-title":"Mendelian randomization: concepts and scope","volume":"12","author":"Richmond","year":"2022","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1039\/c8fo02265h","article-title":"Dietary inulin alleviates diverse stages of type 2 diabetes mellitus via anti-inflammation and modulating gut microbiota in db\/db mice","volume":"10","author":"Li","year":"2019","journal-title":"Food Funct"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1586\/1744666X.2016.1101344","article-title":"Immunological basis in the pathogenesis of intrahepatic cholestasis of pregnancy","volume":"12","author":"Larson","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.3390\/nu12113444","article-title":"Fructose-induced intestinal microbiota shift following two types of short-term high-fructose dietary phases","volume":"12","author":"Beisner","year":"2020","journal-title":"Nutrients"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"1802866","DOI":"10.1080\/19490976.2020.1802866","article-title":"Gut microbes from the phylogenetically diverse genus Eubacterium and their various contributions to gut health","volume":"12","author":"Mukherjee","year":"2020","journal-title":"Gut Microbes"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3389\/fmicb.2016.00979","article-title":"Bifidobacteria and butyrate-producing Colon Bacteria: importance and strategies for their stimulation in the human gut","volume":"7","author":"Riviere","year":"2016","journal-title":"Front Microbiol"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.clnu.2019.02.037","article-title":"Unconjugated and secondary bile acid profiles in response to higher-fat, lower-carbohydrate diet and associated with related gut microbiota: a 6-month randomized controlled-feeding trial","volume":"39","author":"Wan","year":"2020","journal-title":"Clin Nutr"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"9124","DOI":"10.1021\/acs.jafc.8b07306","article-title":"Review on bile acids: effects of the gut microbiome, interactions with dietary Fiber, and alterations in the bioaccessibility of bioactive compounds","volume":"67","author":"Singh","year":"2019","journal-title":"J Agric Food Chem"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41588-021-00992-y","article-title":"Effect of host genetics on the gut microbiome in 7,738 participants of the Dutch microbiome project","volume":"54","author":"Lopera-Maya","year":"2022","journal-title":"Nat Genet"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1859397\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T05:56:30Z","timestamp":1781675790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1859397\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":90,"alternative-id":["10.3389\/fmed.2026.1859397"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1859397","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"article-number":"1859397"}}